Fedetz M - Search Results

1

Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes.

Varadé J, Comabella M, Ortiz MA, Arroyo R, Fernández O, Pinto-Medel MJ, Fedetz M, Izquierdo G, Lucas M, Gómez CL, Rabasa AC, Alcina A, Matesanz F, Alloza I, Antigüedad A, García-Barcina M, Otaegui D, Olascoaga J, Saiz A, Blanco Y, Montalbán X, Vandenbroeck K, Urcelay E. Varadé J, et al. Among authors: fedetz m. Mult Scler. 2012 Jul;18(7):959-65. doi: 10.1177/1352458511432741. Epub 2011 Dec 22. Mult Scler. 2012. PMID: 22194214

2

Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.

Matesanz F, Fedetz M, Collado-Romero M, Fernández O, Guerrero M, Delgado C, Alcina A. Matesanz F, et al. Among authors: fedetz m. J Neuroimmunol. 2001 Sep 3;119(1):101-5. doi: 10.1016/s0165-5728(01)00354-x. J Neuroimmunol. 2001. PMID: 11525806

3

The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis.

Fedetz M, Matesanz F, Pascual M, Martín J, Fernández O, Guerrero M, Alcina A. Fedetz M, et al. J Neurol Sci. 2001 Sep 15;190(1-2):69-72. doi: 10.1016/s0022-510x(01)00595-0. J Neurol Sci. 2001. PMID: 11574109

4

Analysis of -631 and -475 interleukin-2 promoter single nucleotide polymorphisms in multiple sclerosis.

Fedetz M, Alcina A, Fernández O, Guerrero M, Delgado C, Matesanz F. Fedetz M, et al. Eur J Immunogenet. 2002 Oct;29(5):389-90. doi: 10.1046/j.1365-2370.2002.00338.x. Eur J Immunogenet. 2002. PMID: 12358847

5

Lack of association between -384 and 114 IL-2 gene polymorphisms and rheumatoid arthritis.

Fedetz M, Matesanz F, Cáliz R, Ferrer MA, Collado MD, Alcina A, Martín J. Fedetz M, et al. J Rheumatol. 2003 Mar;30(3):435-7. J Rheumatol. 2003. PMID: 12610796

6

Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.

Matesanz F, Fedetz M, Leyva L, Delgado C, Fernández O, Alcina A. Matesanz F, et al. Among authors: fedetz m. J Neuroimmunol. 2004 Mar;148(1-2):212-7. doi: 10.1016/j.jneuroim.2003.12.001. J Neuroimmunol. 2004. PMID: 14975604

7

IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.

Leyva L, Fernández O, Fedetz M, Blanco E, Fernández VE, Oliver B, León A, Pinto-Medel MJ, Mayorga C, Guerrero M, Luque G, Alcina A, Matesanz F. Leyva L, et al. Among authors: fedetz m. J Neuroimmunol. 2005 Jun;163(1-2):165-71. doi: 10.1016/j.jneuroim.2005.02.010. Epub 2005 Apr 22. J Neuroimmunol. 2005. PMID: 15885318

8

The 1858T PTPN22 gene variant contributes to a genetic risk of type 1 diabetes in a Ukrainian population.

Fedetz M, Matesanz F, Caro-Maldonado A, Smirnov II, Chvorostinka VN, Moiseenko TA, Alcina A. Fedetz M, et al. Tissue Antigens. 2006 May;67(5):430-3. doi: 10.1111/j.1399-0039.2006.00591.x. Tissue Antigens. 2006. PMID: 16671953

9

OAS1 gene haplotype confers susceptibility to multiple sclerosis.

Fedetz M, Matesanz F, Caro-Maldonado A, Fernandez O, Tamayo JA, Guerrero M, Delgado C, López-Guerrero JA, Alcina A. Fedetz M, et al. Tissue Antigens. 2006 Nov;68(5):446-9. doi: 10.1111/j.1399-0039.2006.00694.x. Tissue Antigens. 2006. PMID: 17092260

10

IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility.

Matesanz F, Caro-Maldonado A, Fedetz M, Fernández O, Milne RL, Guerrero M, Delgado C, Alcina A. Matesanz F, et al. Among authors: fedetz m. J Neurol. 2007 May;254(5):682-4. doi: 10.1007/s00415-006-0416-4. Epub 2007 Apr 10. J Neurol. 2007. PMID: 17420929 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters